A Man with Acute Severe Pneumonia:  Case Discussion from the University of Louisville Hospital by Nagarajan, Viswanathan et al.
Presentation of Case
Dr.Viswanathan Nagarajan (Infectious Diseases 
fellow): A 39-year-old previously healthy male presented to the 
emergency room  for sudden onset left sided chest pain, cough 
with blood tinged sputum and shortness of breath, which started 
abruptly six hours prior to the presentation.  He had been to 
another emergency room three days prior with myalgia, fever, 
headache, nausea, vomiting and diarrhea.  Rapid influenza 
screen had been negative at that hospital.  Nevertheless, he 
was discharged on oseltamivir.  Now, shortness of breath was 
at rest and the chest pain was associated with cough and deep 
breathing.  He also continued to have diarrhea and vomiting. 
Apart from having a 27 pack-year history of smoking, marijuana 
use and consuming a pint of alcohol every day, he had no history 
of intravenous drug use.  He lived with his girlfriend, and denied 
promiscuous sexual activity or sex with males.  He denied any 
travel outside of the US, or having pets at home.  He had no 
known drug allergies. 
His temperature was 38.8° Celsius, heart rate 130 beats/min, 
respiratory rate 33 breaths/min, blood pressure 151/83 mm 
Hg, and oxygen saturation 93% on room air (FiO2 21%).  The 
patient was in moderate respiratory distress and was seen using 
accessory muscles of respiration.  He was alert, but unable to 
speak up as his voice was feeble.  He had no signs of clubbing or 
generalized lymphadenopathy.  No needle tracks were observed. 
Lung auscultation revealed equal air entry on both sides with no 
changes in his inspiration to expiration ratio.  Bilateral crackles 
and wheezing were noted on the entire left side.  On percussion, 
no dullness or resonance was noted. 
Diagnostic Approach
Dr. Julio Ramirez (Chief, ID): At this point, let’s say you 
are working in the emergency room and are presented with this 
patient and do not have imaging or laboratory values yet.  What 
do you think?
Dr. Srini Dontineni (ID fellow): It looks like a gentleman 
of 39 years without a history of medical problems who presents 
with fever, hemoptysis, myalgias and everything that appears 
to be an acute infectious process of the respiratory system and 
community-acquired pneumonia (CAP).  It looks bacterial and 
his recent influenza test was negative, so this is unlikely viral, but 
rather bacterial.  The differential for bacterial CAP in this patient 
includes typical pathogens, such as, Streptococcus pneumoniae, 
Haemophilus influenzae and Moraxella catarrhalis as well as 
atypical pathogens, such as, Chlamydia pneumoniae, Legionella 
pneumophila and Mycoplasma pneumoniae. 
Dr. Veronica Corcino (ID fellow): With an acute 
presentation of fever, nausea, and vomiting and developing 
respiratory symptoms that were more remarkable three days 
after being discharged from the emergency room, what is 
important for me is that he is a smoker (two or three packs per 
day).  He could be colonized with many organisms.  He also 
takes a half pint of alcohol and uses marijuana, so I agree with 
Dr. Dontineni’s presentation that because of the respiratory 
symptoms, it could be pneumonia.  What type of pneumonia? 
Maybe he started with some viral symptoms.  He mentioned 
that he started with myalgias and fever the first time he went 
to the emergency room.  I don’t know if he was really negative 
for influenza, but he was discharged on oseltamivir.  They may 
have been thinking about a false negative because of a known 
exposure to someone else.  But the point is he may have had 
some viral infection and then developed a bacterial pneumonia.
He also may have had so much alcohol that he lost consciousness 
and aspirated anaerobic bacteria, such as Peptostreptococcus, 
Fusobacterium, Bacteroides, or Prevotella.  I would also consider 
Klebsiella pneumoniae.  I also don’t know if days before he had 
had a dental procedure?  His symptoms now may be his immune 
system responding to Pneumocystis jiroveci pneumonia (PCP) 
or a bacterial infection, and specifically his pleuritic pain due 
a pneumothorax or to an abscess.  As you know, community-
acquired methicillin-resistant Staphylococcus aureus, and 
Streptococcus species including S. pyogenes, and S. anginosus 
may cause a severe pneumonia.  Atypical organisms were 
mentioned and I agree.  
I was thinking how to tie his vomiting and diarrhea with his 
respiratory symptoms.  Legionella would explain both.  If he 
had HIV, I would inquire about his GI symptoms.  He is not a 
known intravenous drug user, but he does smoke marijuana, 
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so there is a suspicion.  Of course, if blood cultures are positive 
then he might have infective endocarditis, which is always in our 
differential.  I think a fungal etiology is less likely. 
Dr. Ramirez: You ran through the chapter of community-
acquired pneumonia (CAP).  You told us almost all the 
organisms that can cause CAP.  Then, to both of you, if you can 
tell me one consideration, what do you think happened with this 
patient.  What would be most likely?
Dr. Dontineni: Pneumonia acquired in the community.
Dr. Corcino: With these respiratory symptoms, we need to see 
the chest X-ray.
Dr. Ramirez: I know, but what would be the story?  Don’t tell 
me the differential.
Dr. Corcino: Acute viral syndrome that caused pneumonia.
Dr. Ramirez: I agree.  The patient has a flu like syndrome 
for which he went to the ER and they did a rapid influenza test 
that was negative, but they are so convinced that it was a false-
negative test that they sent the patient home with oseltamivir. 
So, it seems to me that the patient was having the influenza-
like syndrome that is the classic post-influenza CAP.  That’s the 
story.  Because the patient is a 39 year old with a respiratory 
rate of 33, 92% saturation on 2L/min of oxygen with a cough, 
you don’t need a chest X-ray to diagnose pneumonia.  Unless the 
patient had a pulmonary embolism at 3 o’clock in the morning, 
how do you explain a drop in saturation to 93% on 2L/min in 
a 39 year old?  You have to have a massive VQ mismatch and 
most likely it is pneumonia.   The history is interesting when 
he was in the ER of the other hospital.  He doesn’t complain 
of cough and all of a sudden at 3 o’clock in the morning he 
developed chest pain; he woke up with chest pain.  You know 
this is classical for pneumococcal pneumonia.  It is sudden 
pain like a knife [stabbing sound].  So this seems to me to be a 
case of post-influenza CAP due to S. pneumoniae, or possibly 
S. aureus.  The patient had blood in his sputum, so he may 
have had necrotizing pneumonia from community-acquired 
MRSA.  Then the way that this is forming in my mind is that it is 
community-acquired-MRSA due to USA 300 gene with Panton-
Valentine leukocidin (PVL) toxin causing damage [1].  Then my 
primary consideration is probably post-influenza CA-MRSA or 
pneumococcal pneumonia. 
On the CXR, we can expect to see cavities consistent with 
necrotizing pneumonia.  We have discussed that S. aureus is now 
the second most common bacterial cause of CAP.  So, when you 
list the most common pathogens causing CAP, remember to list 
S aureus, and when you say H. influenzae and M. catarrhalis, 
also put S. aureus.  This patient is too sick for a 39 year old to 
have Mycoplasma pneumoniae or Chlamydia pneumoniae. 
Legionella pneumophila, yes.  It is not likely aspiration 
pneumonia, which is more subacute.  You can aspirate all you 
want, but you will never be this hypoxic six hours later.  You 
need time to develop the abscess and progress.  Overall, I would 
consider these things, but from the long differential you listed, 
there are a lot of things that this is not.  It has to be some acute 
organisms that can make a 39 year old severely sick.
Dr. Raghuram: One point I want to clarify–one of you 
mentioned that the rapid flu test was negative, so it was 
unlikely influenza, but the sensitivity of that test is between 
50-70%, so just because it  is negative doesn’t mean that it is 
unlikely.  Another of you mentioned that since the patient 
is immunocompromised we should consider PCP, but this 
presentation is too acute to say that PCP should be in the 
differential, unless he has a pneumothorax.  I agree with the 
comments that this could be post-influenza S. pneumoniae 
or S. aureus.  And I think the third most common pathogen 
in this scenario is influenza.  Even with influenza there are 
associated cardiac complications with myocarditis, pericarditis, 
or myocardial infarction, so any of that could be making this 
presentation worse. 
Dr. Raff: Pneumococcal pneumonia classically has 
hyperbilirubinemia associated with it and often patients appear 
icteric at the onset. On the other hand, he has bilateral rales 
[crackles] and with pneumococcal pneumonia you expect single 
lobe involvement rather than bilateral.  The rapid progression 
of hypoxia with intercostal retractions and the bloody sputum 
tends to be S. aureus as a necrotizing process. I agree that 
H. influenza should also be considered [2]. Subsequently, it 
has been shown that paralysis of the mucociliary border and 
inactivity of pulmonary macrophages makes them susceptible 
to organisms in the nasopharynx - and the organisms are 
pneumococcus, S. aureus, H. influenzae, group A β- strep, 
M. catarrhalis (more in children than adults), and Klebsiella 
pneumoinae (which would explain the hemoptysis, especially in 
an alcoholic).
Dr. Ramirez: Yes, there are a number of bacteria that can 
cause pneumonia after having influenza.  And that’s why H. 
influenza has its name - because it was isolated during outbreaks 
of influenza and it was thought to be the cause at a time before 
viruses were discovered.  With the emergence of community-




Dr. Viswanathan: Initial labs were as follows. (Table 1)  In 
addition, his lactic acid was 2.7 mmol/L, and increased to 5.4 
mmol/L after six hours.  His arterial blood gas on 21% FiO2 had 
a pH of 7.43, pCO2 of 26 mmHg, pO2 of 63 mmHg and HCO3 of 
18 mmol/L.  His total bilirubin was 14.1 mg/dL with direct being 
8.7 mg/dL.  Negative tests included an acute hepatitis panel, 
a human immunodeficiency virus test, and Streptococcal and 
Legionella urinary antigens.  A rapid nasopharyngeal screen for 
respiratory syncytial virus was also negative, but for influenza A 
virus was positive. 
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Table 1 Initial labs for the patient in the emergency room.
WBC 3000 cells/mL 
Hematocrit 45% 
Platelets 121,000 cells/mL 
Sodium 128 mmol/L 
Potassium 3.8 mmol/L 
Chloride 99 mmol/L 
Creatinine 0.9 mg/dL 
Glucose 183 mg/dL 
Phosphate 1.0 mg/dL 
AST 159 U/L 
ALT 109 U/L 
Total bilirubin 14.1 mg/dL 
LDH 1888 U/L 
ESR 4 mm/hr 
ALT, alanine aminotransferase; AST aspartate aminotransferase;  
ESR, erythrocyte sedimentation rate; LDH, lactate dehydrogenase;  
WBC, white blood cell 
 
Dr. Corcino:  The only thing I would expect different in a 
healthy young male being this sick would be a higher white 
blood cell count.
Dr. Dontineni: The most notable abnormalities are his low 
platelets and his low pO2.
Dr. Ramirez: This emphasizes what we just discussed; 
that this patient is extremely sick with manifestations of CAP 
including sepsis, organ failure, a lactic acid of 5.4, platelets close 
to 100,000 cells/mL and a white blood cell count of only 3000 
cells/mL.  Again, any patient with severe CAP and neutropenia 
is community-acquired MRSA until proven otherwise. 
Dr. Viswanathan: His chest radiograph was reviewed. 
(Figure 1)
Discussion
Dr. Dontineni: I don’t see any infiltrate, consolidation, or 
pneumothorax.  The costophrenic angles are clear and the 
trachea is in the midline.
Dr. Corcino:  The right side may have the beginning of an 
infiltrate.
Dr. Ramirez: I am biased because after this presentation I 
am expecting something to be on the chest x-ray.  The patient 
has left-sided chest pain and hemoptysis and he is telling me, 
in essence, to look at his left side.  The outer one third of the 
lung is supposed to be very clear, and as you see, it is not clear 
on the left side.  To me he has an infiltrate.  I don’t want to start 
imagining cavities because it is easy to do when you look at the 
edges of ribs. 
Dr. Viswanathan: The report of the chest radiograph was 
“patchy bilateral airspace opacities (left greater than right); 
cardiomediastinal contours are within normal limits.”  A CT 
scan was obtained. (Figure 2) 
3
Figure 1 Chest radiograph of patient at presentation with respiratory distress.
Figure 2 
(A) CT scan of the chest showing extensive bronchial dilatation and wall 
thickening without pleural or pericaridial effusions, 
(B).Extensive bilateral cavitating pneumonia most likely representing 
septic emboli as well as mediastinal and hilar lymphadenopathy 
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Dr. Ramirez: These findings on the CT scan are impressive but 
you have to be able to find these changes on the portable film. 
There is data to show that you can miss up to 4% of infiltrates 
on a portable chest x-ray.  There was a recent study of 300 
pneumonia patients who received a portable chest radiograph 
and a CT scan [3]. 
There are some areas of necrosis inside of this infiltrate; 
perhaps an abscess or infiltrate around an airway with 
bronchopneumonia.  There is lateral bronchopneumonia with 
upper lobe cavities highly suggestive of S. aureus USA 300 PVL 
toxin positive.  This patient had several criteria for pneumonia 
due to this pathogen, so anti-MRSA treatment should be started 
in the emergency room in this circumstance, in addition to the 
other standard therapy for CAP.  
Dr. Nagarajan: Blood cultures at 48 hours did not show 
any growth.  The patient was transferred to ICU for hypoxic 
respiratory failure, and continued to be short of breath.  Sputum 
for culture and AFB were obtained.  He was placed in respiratory 
isolation and started on ceftriaxone and azithromycin. 
Management
Dr. Ramirez: This patient was not placed on any anti-MRSA 
therapy on day one, except for clindamycin.  The discussion in 
the emergency room for this patient should have been, “Does 
this patient get vancomycin, linezolid or ceftaroline?  What is 
going to be the MRSA therapy?”  Now we recognize that for 
community-acquired MRSA, there is not a single antibiotic that 
has been FDA approved.  We use vancomycin or ceftaroline with 
clindamycin for the antitoxin effect, or linezolid, which already 
has this effect.
Another point is that the Gram’s stain should be obtained and 
evaluated in the emergency room.  We have an arrangement 
with microbiology that if the Division of Infectious Diseases 
orders a Gram’s stain, microbiology will do it stat.  If the patient 
has S. aureus pneumonia, the Gram’s stain should have gram-
positive cocci in clusters.  This allows us to focus therapy for 
MRSA.  It is interesting that they ordered clindamycin because 
they were considering an anaerobic infection due to aspiration, 
but they were actually helping in a different way because of the 
partial coverage for MRSA and its toxins. 
Dr. Nagarajan: The CT of the chest was read as necrotizing 
cavitary pneumonia with septic emboli.  His lactic acid 
improved to 1.4 mmol/L with intravenous fluids.  He continued 
to be febrile (102.3°F), tachycardic (128 beats/min), and 
tachypneic (28 breaths/min) with a room air saturation of 
94%.  His antibiotics were changed to vancomycin, clindamycin, 
piperacillin/tazobactam and levofloxacin.  After 72 hours on the 
ward, he was transferred back to ICU, for worsening respiratory 
status with a heart rate of 132 beats/min and a temperature of 
103.2°F.  The sputum culture grew MRSA after 27 hours.
Dr. Ramirez: For the fellows, we get so accustomed to the 
patient who is in the age range of 60-97 years.  When we have 
a patient who is less than 40, we have a totally different type of 
patient.  This patient who has multi-organ system failure and 
evidence of sepsis needs to be monitored closely.  Furthermore, 
every patient who has sepsis is dehydrated and will improve 
slightly with rehydration, but this is not the point.  MRSA is 
an aggressive form of pneumonia.  When does the MRSA stop 
necrotizing the lungs?  You need three or four days of antibiotics. 
For the first one or two days of antibiotics, no clinically relevant 
pathophysiological progress occurs.  And if vancomycin is 
started, it takes a while to become therapeutic; sometimes days. 
What was the Gram’s stain?
Dr. Nagarajan: I didn’t look at it.  The blood cultures grew 
MRSA three times in four days.  His transesophageal echo was 
negative for any vegetations.
Dr. Ramirez: We should always look at the Gram’s stains.  So, 
he had persistent MRSA bacteremia.
Dr. Raff: What percentage of patients with staphylococcal 
pneumonia are demonstratively bacteremic?
Dr. Ramirez: You know it’s interesting and I don’t know the 
percentage, but we just put an opinion piece in ULJRI (The 
University of Louisville Journal of Respiratory Infections) 
of how to treat S. aureus pneumonia with bacteremia [4] 
We suspect that it is high because S. aureus is an aggressive 
pathogen.  For pneumococcal pneumonia, bacteremia is 20-
30% [5], but for S. aureus, we don’t have a value. 
I am reminded of when community-acquired MRSA first came 
about.  This patient reminds me of a 35-year-old female who 
was admitted and died.  She developed bronchopneumonia, 
was admitted to the ward and then transferred to the ICU where 
she was intubated and mechanically ventilated.  She had an 
empyema complicated by a fistula and then she died of multi-
organ failure.  It took years to establish empiric therapy for 
MRSA in CAP patients with risk factors.  We actually don’t know 
if community-acquired MRSA is more virulent or if community-
acquired MRSA becomes worse because coverage for MRSA is 
delayed for the first 48 hours.  
Who is responsible here?  Many pathogens causing pneumonia 
are aggressive, and a patient may die if treatment is delayed for 
48 hours.  There is discussion that receiving antibiotics within 4 
hours of presenting to the hospital may be associated with better 
outcomes than 8 hours.  Imagine not receiving antibiotics for 48 
hours! This patient was started on vancomycin on the second 
day over 24 hours after presenting to the hospital with a level 
that probably wasn’t therapeutic for another day or two.
This patient has bronchopneumonia and now we start seeing 
what was a tiny area on the initial X-ray.  We can now clearly 
see necrotizing pneumonia.  At this point, some expert opinions 
suggest administering immunoglobulins for this patient, 
although there is not data to support its use.  The idea is that 
since PVL is just one toxin among many that we are exposed 
to throughout our lifetime from S. aureus, and to which we 
develop antibodies, immunoglobulin therapy may be another 
way to treat severe Staphylococcal infection.  So this would be 
going back in history to give antibodies for pneumonia the same 
way they did in the pre-penicillin era. 
Dr. Raff: Except they were using horse serum!
Dr. Ramirez: Yes; horse serum.  So, here we would be 
giving antibiotics, antitoxins and immunoglobulins (meaning 
antibodies).
Dr. Nagarajan: The ICU started levofloxacin then de-escalated 
antibiotics to only vancomycin. 
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Dr. Ramirez: The point here is that in our study of 
community-acquired MRSA pneumonia, there is no study that 
is perfect.  Linezolid was associated with better outcomes than 
vancomycin.  But in all the studies comparing vancomycin and 
linezolid the question was whether linezolid is actually better or 
is vancomycin worse since a level was not therapeutic for the 
initial days.  If we use vancomycin, we need to give a loading 
dose to be sure we get a therapeutic level on day one.  And this 
is what you had here, except even with the loading dose you 
didn’t have a therapeutic level until day four or five.  For severely 
ill patients with community-acquired MRSA, we cannot be 
dependent on an antibiotic if we don’t know that it is therapeutic 
on day one.  Another point is that we do not typically even get a 
level on day one, because we know that the level is going to be 
low.  Is six hours or eight hours going to make a difference?  In 
this population, probably so.  For these patients we should not 
use vancomycin. 
Dr. Nagarajan: Pharmacy recommended the dosing. (Table 
2)  There was a difficulty bringing vancomycin to therapeutic 
levels.
Dr. Ramirez: This reminds me of the patients in the trauma 
unit years ago who had persistently low levels of aminoglycoside 
in the surgical ICU.  It didn’t matter how much antibiotic we 
gave them, the levels never reached a therapeutic range because 
they metabolized it so quickly.  Some young people were very 
difficult to attain a therapeutic level for an antibiotic.  To me, the 
drug of choice for MRSA pneumonia is linezolid.
Dr. Nagarajan: He did reach a therapeutic level of 19 µg/
mL on 2.5 g of vancomycin every eight hours on hospital day 
# 11.  Linezolid was added on day four.  And vancomycin was 
continued. 
Dr. Ramirez: Eleven days?!  I don’t need to emphasize my 
point any further.  What was the MIC to vancomycin? 
Dr. Nagarajan: One.  The organism was found to be sensitive 
to vancomycin, clindamycin, tetracycline, trimethoprim/
sulfamethoxazole and linezolid.  On hospital day 12, he 
developed right-sided weakness and an MRI showed nonspecific 
changes.  Another TEE found a small PFO with no vegetation. 
Ultimately, he defevesced and his oxygen saturation improved 
to 96% on room air with linezolid the following day. 
Dr. Ramirez: When the community-associated MRSA 
epidemic started here, we had a few patients die with 
pneumonia.  I remember that it was a big debate because 
linezolid was still very expensive, and its use was restricted 
to the Division of Infectious Diseases.  The problem was that 
Infectious Diseases was being called on day three, which was 
preventing patients from linezolid’s early antitoxin benefit.  So, 
with the antimicrobial stewardship team, we approached the 
emergency department and told them that we wanted them 
to use linezolid in a young person with a multilobar infiltrate, 
hemoptysis, and neutropenia who was going to be admitted to 
the ICU for CAP- and that they did not need Infectious Diseases’ 
approval.  This was because we preferred to stop inappropriate 
linezolid after 24 hours rather than have appropriate patients go 
without it for 48 hours.  We need to reemphasize our use of anti-
MRSA therapy in the emergency department.
Dr. Nagarajan: The strategy that this division has used in the 
past for patients with this diagnosis is summarized in an article 
by Dr. Peyrani and Dr. Ramirez. [6].
Anatomical Diagnosis
Post-influenza MRSA pneumonia complicated with bacteremia 
and hypoxic respiratory failure. 
This case was presented at the University of Louisville Division 
of Infectious Diseases Patient Management Conference.
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Table 2 Vancomycin levels, dosing and creatinine values for specific days 
of the patient’s hospitalization.
Day Vancomycin Level 
(µg/mL) 




2250 mg once 1.23 
2 12.1 1500 mg q12 hrs 0.98 
4 8.4 1250 mg q8 hrs 0.79 
6 12.8 1500 mg q8 hrs 0.62 
8 9.8 1750 mg q12 hrs 0.59 
10 9.3 2500 mg q8 hrs 0.50 
11 19.6 2250 mg q8 hrs 0.59 
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